Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBreedon Regulatory News (BREE)

Share Price Information for Breedon (BREE)

Share Price is delayed by 15 minutes
Get Live Data
298.60    3.00 (1.01%)
Bid:
298.00
Ask:
298.60
Spread: 0.60 (0.201%)
Market Cap: £1.04b
BREE Live PriceLast checked at - London Stock Exchange

Intraday Breedon Share Chart

Interim Results

2 Sep 2009 15:14

RNS Number : 4174Y
Marwyn Materials Limited
02 September 2009
 



MARWYN MATERIALS LIMITED

UNAUDITED INTERIM RESULTS

FOR THE 6 MONTH PERIOD TO 30 JUNE 2009

Chairman's Statement

I am pleased to present the interim financial statements of Marwyn Materials Limited for the first six months of 2009.

Acquisition strategy

Marwyn Materials Limited was established to acquire controlling interests in building materials businesses, both listed and unquoted, in the UKEurope and US, with a view to creating shareholder value through market consolidation. This continued to be the group's strategy throughout the period under review.

Results

The group's loss after taxation for the period from incorporation to 30 June 2009 was £435,050 which was in line with the expected result for this period. 

Costs incurred to date include £75,000 in relation to due diligence carried out on acquisition targets by the group's professional advisers but with a large proportion of work carried out by the management.

As at 30 June 2009, the group had net cash balances totalling £12.5 million. 

Dividends

It is the board's policy that prior to making the first acquisition, no dividends will be paid. Following the first acquisition, subject to availability of distributable reserves, dividends will be paid to shareholders when the directors believe it is appropriate and prudent to do so. However, the main focus of the group will be on delivering capital growth for shareholders.

Outlook

The group continues to pursue its stated acquisition strategy. The short term trading performance for building materials businesses has remained difficult and we continue to review a number of opportunities to acquire attractive assets at a cyclical low point for the industry. 

We believe that Marwyn Materials, with its strong and experienced management team, is well placed to exploit the available opportunities as they arise. 

Peter Tom

Chairman

2nd September 2009

Enquiries: 

 

 

Marwyn Materials Limited 

Peter Tom 020 7389 6800 

Simon Vivian 020 7389 6800 

 

 

Cenkos Securities plc 

Nicholas Wells 020 7397 8920

 

 

CONDENSED CONSOLIDATED STATEMENT OF FINANCIAL POSITION

 
 
30 June 2009 (unaudited)
 
31 December 2008 (audited)
 
 
£
 
£
 
Assets
 
 
 
 
 
 
 
 
 
 
 
Receivables
 
7,726
 
14,195
Cash and cash equivalents
 
12,450,273
 
12,806,100
Total current assets
 
12,457,999
 
12,820,295
Total assets
 
12,457,999
 
12,820,295
 
 
 
 
 
Equity
 
 
 
 
Share capital
 
13,262,480
 
13,262,480
Equity-settled employee benefits reserve
 
1,263
 
680
Accumulated losses
 
(1,177,545)
 
(742,495)
Total equity attributable to the shareholders of the Company
 
12,086,198
 
12,520,665
Total equity
 
12,086,198
 
12,520,665
 
 
 
 
 
Non-current liabilities
 
 
 
 
Taxation
 
5,048
 
1,913
Total non-current liabilities
 
5,048
 
1,913
 
 
 
 
 
Current liabilities
 
 
 
 
Trade and other payables
 
366,753
 
297,717
Total current liabilities
 
366,753
 
297,717
Total liabilities
 
371,801
 
299,630
Total equity and liabilities
 
12,457,999
 
12,820,295

These condensed interim financial statements were approved and authorised for issue by the Board of Directors on 2nd September 2009 and signed on its behalf by:

Peter Tom CBE Simon Vivian

Chairman Chief Executive

CONDENSED CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME

For the 6 months ended 30 June

 
 
2009 (unaudited) 
 
2008 (unaudited) 
 
 
£
 
£
 
 
 
 
 
Interest income
 
60,733
 
-
 
 
 
 
 
Employee expenses
 
(128,224)
 
-
Professional and consultancy expenses
 
(309,419)
 
(62,349)
Other expenses
 
(55,006)
 
(3,133)
 
 
(492,649)
 
(65,482)
 
 
 
 
 
Results from operating activities
 
(431,916)
 
(65,482)
 
 
 
 
 
Loss before income tax
 
(431,916)
 
(65,482)
 
 
 
 
 
Income tax expense
 
(3,134)
 
-
Loss for the period
 
(435,050)
 
(65,482)
Other comprehensive income
 
-
 
-
Total comprehensive income for the period
 
(435,050)
 
(65,482)
 
 
 
 
 
Attributable to:
 
 
 
 
Owners of the Company
 
(435,050)
 
(65,482)
Total comprehensive income for the period
 
(435,050)
 
(65,482)
 
 
 
 
 
Earnings per share
 
 
 
 
Basic and diluted loss per share
 
(0.32p)
 
(0.46p)

All the group's activities derive from continuing operations.

CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN EQUITY

For the 6 months ended 30 June 2008 (unaudited)

 
 
 
 
 
 
 
Share capital
Equity-settled employee
 benefits
reserve
Accumulated losses
Total
 
 
£
£
£
£
 
Balance at 1 January 2008
2
 
-
(600)
(598)
 
Loss for the period
-
 
-
(65,482)
(65,482)
 
Other comprehensive income 
-
 
-
-
-
 
Total comprehensive income
-
 
-
(65,482)
(65,482)
 
Recognition of share-based payments 
-
 
93
-
93
 
Issue of ordinary shares during the period
13,599,998
-
-
13,599,998
 
Costs directly related to the issue of capital
(337,520)
-
-
(337,520)
 
 
Balance at 30 June 2008
13,262,480
 
93
(66,082)
13,196,491
 

For the 6 months ended 30 June 2009 (unaudited)

 
 
 
 
 
 
Share capital
Equity- settled employee
benefits
reserve
Accumulated losses
Total
 
 
£
£
£
£
 
Balance at 1 January 2009
13,262,480
 
680
(742,495)
12,520,665
 
Loss for the period
-
-
(435,050)
(435,050)
 
Other comprehensive income 
-
-
-
-
 
Total comprehensive income
-
-
(435,050)
(435,050)
 
Recognition of share-based payments 
-
583
-
583
 
Issue of ordinary shares during the period
 
 
 
 
 
Costs directly related to the issue of capital
 
 
 
 
 
Balance at 30 June 2009
13,262,480
1,263
(1,177,545)
12,086,198
 

All the group's activities derive from continuing operations.

CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS

For the 6 months ended 30 June

 
 
 
2009
(unaudited) 
 
2008
(unaudited) 
 
 
 
£
 
£
 
 
 
 
 
 
Cash flows from operating activities:
 
 
 
 
 
Interest received
 
 
69,768
 
-
Payments to suppliers and employees
 
 
(425,595)
 
-
Net cash generated by operating activities
 
 
(355,827)
 
-
Cash flows from financing activities:
 
 
 
 
 
Proceeds from issue of share capital
 
 
-
 
13,600,000
Payment for share issue costs
 
 
-
 
(337,520)
Net cash from financing activities
 
 
-
 
13,262,480
 
 
 
 
 
 
Net decrease in cash and cash equivalents
 
 
(355,827)
 
13,262,480
Cash and cash equivalents at 1 January
 
 
12,806,100
 
-
Cash and cash equivalents at 30 June
 
 
12,450,273
 
13,262,480

1. Reporting entity

 

Marwyn Materials Limited (the "Company") is a company domiciled in Jersey. The address of the Company's registered office is Elizabeth House, 9 Castle Street, St Helier, JerseyJE2 3RT

The Company is listed on the Alternative Investment Market ("AIM").

This condensed consolidated interim financial information has not been audited and was approved for issue on 2nd September 2009.

 

 

2.Statement of compliance

 

These condensed consolidated interim financial statements for the six months ended 30 June 2009 have been prepared in accordance with International Accounting Standard (IAS) 34 'Interim Financial Reporting', as adopted by the European Union.  The condensed consolidated interim financial statements should be read in conjunction with the annual financial statements for the year ended 31 December 2008.

 

3. Accounting policies 

 

The accounting policies applied are consistent with those of the annual financial statements for the year ended 31 December 2008, as described in those annual financial statements, except for the adoption of new standards and interpretations as noted below:

− IAS 1 (revised), 'Presentation of financial statements'. The revised standard prohibits the presentation of items of income and expenses (that is 'non-owner change in equity') in the consolidated statement of changes in equity, requiring 'non-owner changes in equity' to be presented separately from owner changes in equity. All 'non-owner changes in equity' are required to be shown in a performance statement. Entities can choose whether to present one performance statement (the statement of comprehensive income) or two statements (the income statement and statement of comprehensive income). The group has elected to present one consolidated statement of comprehensive income. The interim financial statements have been prepared under the revised disclosure requirements which had no impact.

− IFRS 8, 'Operating segments'. IFRS 8 replaces IAS 14, 'Segment reporting'. It requires a 'management approach' under which segment information is presented on the same basis as that used for internal reporting purposes. This has not resulted in any change to the presentation. The Directors are of the opinion that the group is engaged in a single geographic and economic business segment. 

The International Accounting Standards Board's Annual Improvements Project was published in May 2008, with the majority of changes being applicable for the period commencing 1 January 2009. The project made minor amendments to a number of standards, primarily with a view to removing inconsistencies and clarifying wording. The amendments to these standards did not have any impact on the accounting policies, financial position or performance of the group.

Taxes on income in the interim periods are accrued using the tax rate that would be applicable to expected total annual earnings. 

 

4. Seasonality

 

The group does not currently operate in an industry where significant or cyclical variations as a result of seasonal activity are experienced during the financial year. 

 

5. Dividend 

 

It is the board's policy that prior to making the first acquisition, no dividends will be paid. Following the first acquisition, subject to availability of distributable reserves, dividends will be paid to shareholders when the directors believe it is appropriate and prudent to do so. However, the main focus of the group will be on delivering capital growth for shareholders.

 6. Earnings per share

Basic earnings per share 

The calculation of basic earnings per share at 30 June 2009 (0.32p loss) was based on the loss attributable to ordinary shareholders of £435,050 and a weighted average number of ordinary shares outstanding of 136m.

The calculation of basic earnings per share at 30 June 2008 (0.46p loss) was based on the loss attributable to ordinary shareholders of £65,482 and a weighted average number of ordinary shares outstanding of 14.2m.

Diluted earnings per share  

The calculation of basic earnings per share at 30 June 2009 (0.32p loss) was based on the loss attributable to ordinary shareholders of £435,050 and a weighted average number of ordinary shares outstanding of 136m. The Participation Shares in issuance during the period are not included in the calculation of weighted average outstanding ordinary shares for the diluted earnings per share calculation as the effect is anti-dilutive.

The calculation of basic earnings per share at 30 June 2008 (0.46p loss) was based on the loss attributable to ordinary shareholders of £65,482 and a weighted average number of ordinary shares outstanding of 14.2m. The Participation Shares in issuance during the period are not included in the calculation of weighted average outstanding ordinary shares for the diluted earnings per share calculation as the effect is anti-dilutive.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IR XLLFBKKBEBBV
Date   Source Headline
7th Jul 20217:00 amRNSBlock listing Update
1st Jul 20216:16 pmRNSTotal Voting Rights
1st Jun 20213:49 pmRNSStandard form for notification of major holdings
1st Jun 20217:00 amRNSAcquisition
28th May 202110:02 amRNSTotal Voting Rights
7th May 20219:28 amRNSStandard form for notification of major holdings
23rd Apr 20211:46 pmRNSDirectors’ and PDMRs’ Dealings
23rd Apr 20211:37 pmRNSPDMR Dealings
20th Apr 20212:36 pmRNSResult of AGM
20th Apr 20217:00 amRNSAGM Trading Update
1st Apr 202111:04 amRNSGrant of SAYE Options and PDMR Dealings
1st Apr 20217:00 amRNSBoard Update
23rd Mar 202111:13 amRNSDirector Dealings
23rd Mar 202111:09 amRNS2020 Annual Report and Notice of AGM
10th Mar 20217:01 amRNSDirectorate Change
10th Mar 20217:00 amRNSAnnual Results 2020
26th Feb 20219:15 amRNSTotal Voting Rights
22nd Jan 20211:55 pmRNSDirector/PDMR Shareholding
22nd Jan 20218:46 amRNSAdditional Block Listing of Ordinary Shares
13th Jan 20217:00 amRNSAppointment of Corporate Broker
7th Jan 20212:45 pmRNSBlock listing Interim Review
23rd Dec 20207:00 amRNSTotal Voting Rights
21st Dec 20207:00 amRNSTrading Update
3rd Dec 20207:00 amRNSUpdate on CMA's Review of Completed Acquisition
2nd Dec 20203:55 pmRNSHolding(s) in Company
1st Dec 20204:50 pmRNSHolding(s) in Company
1st Dec 20207:10 amRNSUpdate on CMA's Review of Completed Acquisition
30th Nov 20201:31 pmRNSTotal Voting Rights
24th Nov 20204:55 pmRNSHolding(s) in Company
24th Nov 20207:00 amRNSDirectorate Change
18th Nov 20207:00 amRNSTrading Update
9th Nov 20207:00 amRNSAcquisition update
30th Oct 20207:00 amRNSTotal Voting Rights
6th Oct 20207:00 amRNSDirectorate Change
30th Sep 20207:00 amRNSTotal Voting Rights
17th Sep 20207:00 amRNSTrading Update
10th Sep 20207:13 amRNSCMA's Review of Completed Acquisition
7th Sep 202012:50 pmRNSGrant of SAYE Options and PDMR Dealings
27th Aug 20202:53 pmRNSDirectors' and PDMRs' Dealings
26th Aug 20207:14 amRNSCMA's Review of Proposed Acquisition
19th Aug 20205:30 pmRNSHolding(s) in Company
19th Aug 20205:30 pmRNSHolding(s) in Company
13th Aug 20204:09 pmRNSDirector and PDMR Dealings
3rd Aug 20207:00 amRNSCompletion of acquisition
31st Jul 20207:00 amRNSTotal Voting Rights
29th Jul 20207:00 amRNSHalf-year Report
8th Jul 20207:00 amRNSBlock listing Interim Review
6th Jul 202010:30 amRNSHolding(s) in Company
6th Jul 202010:30 amRNSHolding(s) in Company
19th Jun 20203:41 pmRNSDirector and PDMR Dealings & Issue of Equity

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.